Cargando…
The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk
Hepatocellular carcinoma (HCC) is a worldwide health issue. Epigenetic alterations play a crucial role in HCC tumorigenesis. Using epigenetic modulators for HCC treatment confers a promising therapeutic effect. The aim of this study was to explore the effect of a decitabine (DAC) and vorinostat (VOR...
Autores principales: | Salama, Basant M., Helmy, Maged W., Fouad, Hosny, Shamaa, Marium M., Houssen, Maha E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378248/ https://www.ncbi.nlm.nih.gov/pubmed/37504291 http://dx.doi.org/10.3390/cimb45070375 |
Ejemplares similares
-
Direct but No Transgenerational Effects of Decitabine and Vorinostat on Male Fertility
por: Kläver, Ruth, et al.
Publicado: (2015) -
Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib
por: Salahuddin, Muhammed M., et al.
Publicado: (2021) -
Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
por: Young, Christine S., et al.
Publicado: (2017) -
Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells
por: Leng, Ennian, et al.
Publicado: (2018) -
Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway‐related proteins
por: Shamaa, Marium M.
Publicado: (2021)